Watanabe Y - Search Results

1

Specific adoptive immunotherapy with tumor-specific cytotoxic T-lymphocyte clone for murine malignant gliomas.

Yamasaki T, Handa H, Yamashita J, Watanabe Y, Namba Y, Hanaoka M. Yamasaki T, et al. Among authors: watanabe y. Cancer Res. 1984 May;44(5):1776-83. Cancer Res. 1984. PMID: 6608988

2

Augmentation of tumor targeting in a line of glioma-specific mouse cytotoxic T-lymphocytes by retroviral expression of mouse gamma-interferon complementary DNA.

Nishihara K, Miyatake S, Sakata T, Yamashita J, Kikuchi H, Kawade Y, Zu Y, Namba Y, Hanaoka M, Watanabe Y. Nishihara K, et al. Among authors: watanabe y. Cancer Res. 1988 Sep 1;48(17):4730-5. Cancer Res. 1988. PMID: 3136912

3

Establishment of experimental malignant glioma-specific cytotoxic T lymphocyte clone by T cell growth factor.

Yamasaki T, Handa H, Yamashita J, Namba Y, Watanabe Y, Kuwata S, Hanaoka M. Yamasaki T, et al. Among authors: watanabe y. J Neurosurg. 1984 May;60(5):998-1004. doi: 10.3171/jns.1984.60.5.0998. J Neurosurg. 1984. PMID: 6201598

4

Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects.

Yamasaki T, Handa H, Yamashita J, Watanabe Y, Namba Y, Hanaoka M. Yamasaki T, et al. Among authors: watanabe y. Neurosurg Rev. 1984;7(1):37-54. doi: 10.1007/BF01743289. Neurosurg Rev. 1984. PMID: 6611523

5

Efficient tumor suppression by glioma-specific murine cytotoxic T lymphocytes transfected with interferon-gamma gene.

Miyatake S, Nishihara K, Kikuchi H, Yamashita J, Namba Y, Hanaoka M, Watanabe Y. Miyatake S, et al. Among authors: watanabe y. J Natl Cancer Inst. 1990 Feb 7;82(3):217-20. doi: 10.1093/jnci/82.3.217. J Natl Cancer Inst. 1990. PMID: 2104938

6

Immunoregulatory role in gamma interferon production by a T cell growth factor-dependent experimental malignant glioma-specific cytotoxic T lymphocyte clone.

Yamasaki T, Handa H, Yamashita J, Watanabe Y, Taguchi M, Kuwata S, Namba Y, Hanaoka M. Yamasaki T, et al. Among authors: watanabe y. J Neurosurg. 1985 Nov;63(5):763-70. doi: 10.3171/jns.1985.63.5.0763. J Neurosurg. 1985. PMID: 3932609

7

Suppressor cell induction factor: a new mediator released by stimulated human lymphocytes and distinct from previously described lymphokines.

Kasakura S, Taguchi M, Watanabe Y, Okubo T, Murachi T, Uchino H, Hanaoka M. Kasakura S, et al. Among authors: watanabe y. J Immunol. 1983 Jun;130(6):2720-6. J Immunol. 1983. PMID: 6222115

8

A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).

Kasakura S, Taguchi M, Watanabe Y, Okubo T, Murachi T, Uchino H, Hanaoka M. Kasakura S, et al. Among authors: watanabe y. J Immunol. 1984 Dec;133(6):3084-90. J Immunol. 1984. PMID: 6238094

9

[Outpatient chemotherapy with continuous infusion of 5-fluorouracil (CI 5-FU) and intravenous bolus leucovorin (IVB LV) in advanced gastrointestinal cancer: the second report].

Tsuji Y, Yoshihito H, Nakamura T, Watanabe Y, Nakayama N, Ohi M, Kawanishi J, Handa H, Honjo K, Uehara S, et al. Tsuji Y, et al. Among authors: watanabe y. Gan To Kagaku Ryoho. 1995 Dec;22 Suppl 4:439-46. Gan To Kagaku Ryoho. 1995. PMID: 8849290 Clinical Trial. Japanese.

10

Interferon-gamma-producing tumor induces host tumor-specific T cell responses.

Teramura Y, Watanabe Y, Kan N, Masuda T, Kuribayashi K. Teramura Y, et al. Among authors: watanabe y. Jpn J Cancer Res. 1993 Jun;84(6):689-96. doi: 10.1111/j.1349-7006.1993.tb02030.x. Jpn J Cancer Res. 1993. PMID: 8340258 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,109 results

Search Page

Filters